RE:RE:Actually a little surprised to see it under the 50 DMA....jfm1330 wrote: Sad to say, but it smells like another financing is coming. I don't see any other explaination. Same pattern as last November. Everything is fine, the stock has momentum, future is bright, but this management wants to play it as conservative as possible cashwise. Financing not to acquire a third drug, no, just to sit on more cash in case something would go wrong. Pure Thera!
The only way I would be happy to see that is if they do a share offering in conjunction with a move to the NASDAQ.
Otherwise, I would not be a fan of financing 20% below recent highs just to have $$.
bfw